Breast reduction and cancer in the gland remnant

A review

Beniamino Palmieri, Alberto Costa, Giorgia Benuzzi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aims. The main aims of this paper are: (1) to evaluate the impact of partial breast gland removal, for cosmetic or functional reasons on cancer incidence in the long-term post-surgical follow-up; (2) to define the incidental cancer finding during breast reduction; (3) to examine the oncological perspective of contralateral breast reduction in women with post-mastectomy breast reconstruction, (4) to consider the impact of breast reduction techniques as first choice procedure in the treatment of cancers in megalomastia. Methods. We reviewed the clinical articles published in the last 20 years addressed to the relationship between the amount of tissue removed and cancerogenesis of the remnant gland. The review has been also extended to published papers outlining the future trends of breast reduction procedures from an oncological perspective, potentially as specific choice of selected cancer treatment in megalomastia. Results. Assessment of the literature data reveals that breast reduction does decrease the risk of breast and other types of cancers. The actual risk lowering for patients older than 40 is related to the amount of tissue removed. Conclusion. This study illustrates that breast reduction surgery should be encouraged, besides the known aims, as a preventive operation in those patients presenting degrees of breast hypertrophy and a family history of breast cancer.

Original languageEnglish
Pages (from-to)283-290
Number of pages8
JournalBreast Cancer Research and Treatment
Volume91
Issue number3
DOIs
Publication statusPublished - Jun 2005

Fingerprint

Breast
Breast Neoplasms
Neoplasms
Incidental Findings
Mammaplasty
Mastectomy
Cosmetics
Hypertrophy
Incidence
Therapeutics

Keywords

  • Breast cancer
  • Breast hypertrophy
  • Breast reduction
  • Gigantomastia
  • Incidental breast cancer finding

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Breast reduction and cancer in the gland remnant : A review. / Palmieri, Beniamino; Costa, Alberto; Benuzzi, Giorgia.

In: Breast Cancer Research and Treatment, Vol. 91, No. 3, 06.2005, p. 283-290.

Research output: Contribution to journalArticle

Palmieri, Beniamino ; Costa, Alberto ; Benuzzi, Giorgia. / Breast reduction and cancer in the gland remnant : A review. In: Breast Cancer Research and Treatment. 2005 ; Vol. 91, No. 3. pp. 283-290.
@article{1ba942c7dfa341bfb9cbab1b9cfc31d3,
title = "Breast reduction and cancer in the gland remnant: A review",
abstract = "Aims. The main aims of this paper are: (1) to evaluate the impact of partial breast gland removal, for cosmetic or functional reasons on cancer incidence in the long-term post-surgical follow-up; (2) to define the incidental cancer finding during breast reduction; (3) to examine the oncological perspective of contralateral breast reduction in women with post-mastectomy breast reconstruction, (4) to consider the impact of breast reduction techniques as first choice procedure in the treatment of cancers in megalomastia. Methods. We reviewed the clinical articles published in the last 20 years addressed to the relationship between the amount of tissue removed and cancerogenesis of the remnant gland. The review has been also extended to published papers outlining the future trends of breast reduction procedures from an oncological perspective, potentially as specific choice of selected cancer treatment in megalomastia. Results. Assessment of the literature data reveals that breast reduction does decrease the risk of breast and other types of cancers. The actual risk lowering for patients older than 40 is related to the amount of tissue removed. Conclusion. This study illustrates that breast reduction surgery should be encouraged, besides the known aims, as a preventive operation in those patients presenting degrees of breast hypertrophy and a family history of breast cancer.",
keywords = "Breast cancer, Breast hypertrophy, Breast reduction, Gigantomastia, Incidental breast cancer finding",
author = "Beniamino Palmieri and Alberto Costa and Giorgia Benuzzi",
year = "2005",
month = "6",
doi = "10.1007/s10549-005-0094-4",
language = "English",
volume = "91",
pages = "283--290",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York LLC",
number = "3",

}

TY - JOUR

T1 - Breast reduction and cancer in the gland remnant

T2 - A review

AU - Palmieri, Beniamino

AU - Costa, Alberto

AU - Benuzzi, Giorgia

PY - 2005/6

Y1 - 2005/6

N2 - Aims. The main aims of this paper are: (1) to evaluate the impact of partial breast gland removal, for cosmetic or functional reasons on cancer incidence in the long-term post-surgical follow-up; (2) to define the incidental cancer finding during breast reduction; (3) to examine the oncological perspective of contralateral breast reduction in women with post-mastectomy breast reconstruction, (4) to consider the impact of breast reduction techniques as first choice procedure in the treatment of cancers in megalomastia. Methods. We reviewed the clinical articles published in the last 20 years addressed to the relationship between the amount of tissue removed and cancerogenesis of the remnant gland. The review has been also extended to published papers outlining the future trends of breast reduction procedures from an oncological perspective, potentially as specific choice of selected cancer treatment in megalomastia. Results. Assessment of the literature data reveals that breast reduction does decrease the risk of breast and other types of cancers. The actual risk lowering for patients older than 40 is related to the amount of tissue removed. Conclusion. This study illustrates that breast reduction surgery should be encouraged, besides the known aims, as a preventive operation in those patients presenting degrees of breast hypertrophy and a family history of breast cancer.

AB - Aims. The main aims of this paper are: (1) to evaluate the impact of partial breast gland removal, for cosmetic or functional reasons on cancer incidence in the long-term post-surgical follow-up; (2) to define the incidental cancer finding during breast reduction; (3) to examine the oncological perspective of contralateral breast reduction in women with post-mastectomy breast reconstruction, (4) to consider the impact of breast reduction techniques as first choice procedure in the treatment of cancers in megalomastia. Methods. We reviewed the clinical articles published in the last 20 years addressed to the relationship between the amount of tissue removed and cancerogenesis of the remnant gland. The review has been also extended to published papers outlining the future trends of breast reduction procedures from an oncological perspective, potentially as specific choice of selected cancer treatment in megalomastia. Results. Assessment of the literature data reveals that breast reduction does decrease the risk of breast and other types of cancers. The actual risk lowering for patients older than 40 is related to the amount of tissue removed. Conclusion. This study illustrates that breast reduction surgery should be encouraged, besides the known aims, as a preventive operation in those patients presenting degrees of breast hypertrophy and a family history of breast cancer.

KW - Breast cancer

KW - Breast hypertrophy

KW - Breast reduction

KW - Gigantomastia

KW - Incidental breast cancer finding

UR - http://www.scopus.com/inward/record.url?scp=21244444671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21244444671&partnerID=8YFLogxK

U2 - 10.1007/s10549-005-0094-4

DO - 10.1007/s10549-005-0094-4

M3 - Article

VL - 91

SP - 283

EP - 290

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -